U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Glanzmann thrombasthenia(GT; BDPLT2; GT1)

MedGen UID:
52736
Concept ID:
C0040015
Disease or Syndrome
Synonyms: BLEEDING DISORDER, PLATELET-TYPE, 2; Diacyclothrombopathia 2B 3A; Glanzmann thrombasthenia type A; Glanzmann's thrombasthenia; PLATELET GLYCOPROTEIN IIb-IIIa DEFICIENCY; Thrombasthenia; Thrombasthenia of Glanzmann and Naegeli; Thrombasthenia of Glanzmann and Naegeli, ITGA2B-Related; Thrombasthenia of Glanzmann and Naegeli, ITGB3-Related
SNOMED CT: Hereditary hemorrhagic thrombasthenia (32942005); Glanzmann's syndrome (32942005); Glanzmann's thrombasthenia (32942005); Glanzmann's disease (32942005); Hereditary thromboasthenia (32942005); Glanzmann thromboasthenia (32942005); Glanzmann-Naegeli disorder (32942005); Thrombasthenia (32942005)
Modes of inheritance:
Autosomal recessive inheritance
MedGen UID:
141025
Concept ID:
C0441748
Intellectual Product
Source: Orphanet
A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in individuals with two pathogenic alleles, either homozygotes (two copies of the same mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele).
 
Monarch Initiative: MONDO:0100326
OMIM®: 273800; 607759
OMIM® Phenotypic series: PS273800
Orphanet: ORPHA849

Definition

Glanzmann thrombasthenia is a bleeding disorder that is characterized by prolonged or spontaneous bleeding starting from birth. People with Glanzmann thrombasthenia tend to bruise easily, have frequent nosebleeds (epistaxis), and may bleed from the gums. They may also develop red or purple spots on the skin caused by bleeding underneath the skin (petechiae) or swelling caused by bleeding within tissues (hematoma). Glanzmann thrombasthenia can also cause prolonged bleeding following injury, trauma, or surgery (including dental work). Women with this condition can have prolonged and sometimes abnormally heavy menstrual bleeding. Affected women also have an increased risk of excessive blood loss during pregnancy and childbirth.

About a quarter of individuals with Glanzmann thrombasthenia have bleeding in the gastrointestinal tract, which often occurs later in life. Rarely, affected individuals have bleeding inside the skull (intracranial hemorrhage) or joints (hemarthrosis).

The severity and frequency of the bleeding episodes in Glanzmann thrombasthenia can vary greatly among affected individuals, even in the same family. Spontaneous bleeding tends to become less frequent with age. [from MedlinePlus Genetics]

Clinical features

From HPO
Subdural hemorrhage
MedGen UID:
6775
Concept ID:
C0018946
Pathologic Function
Hemorrhage occurring between the dura mater and the arachnoid mater.
Intracranial hemorrhage
MedGen UID:
101799
Concept ID:
C0151699
Pathologic Function
Hemorrhage occurring within the skull.
Gastrointestinal hemorrhage
MedGen UID:
8971
Concept ID:
C0017181
Pathologic Function
Hemorrhage affecting the gastrointestinal tract.
Epistaxis
MedGen UID:
4996
Concept ID:
C0014591
Pathologic Function
Epistaxis, or nosebleed, refers to a hemorrhage localized in the nose.
Gingival bleeding
MedGen UID:
42218
Concept ID:
C0017565
Pathologic Function
Hemorrhage affecting the gingiva.
Menorrhagia
MedGen UID:
44358
Concept ID:
C0025323
Pathologic Function
Prolonged and excessive menses at regular intervals in excess of 80 mL or lasting longer than 7 days.
Prolonged bleeding time
MedGen UID:
56231
Concept ID:
C0151529
Finding
Prolongation of the time taken for a standardized skin cut of fixed depth and length to stop bleeding.
Abnormal platelet count
MedGen UID:
488925
Concept ID:
C0580317
Finding
Abnormal number of platelets per volume of blood. In a healthy adult, a normal platelet count is between 150,000 and 450,000 per microliter of blood.
Impaired platelet aggregation
MedGen UID:
383786
Concept ID:
C1855853
Finding
An impairment in the rate and degree to which platelets aggregate after the addition of an agonist that stimulates platelet clumping. Platelet aggregation is measured using aggregometer to measure the optical density of platelet-rich plasma, whereby platelet aggregation causes the plasma to become more transparent.
Decreased platelet glycoprotein IIb-IIIa
MedGen UID:
892761
Concept ID:
C4021767
Finding
Decreased cell membrane concentration of glycoprotein IIb-IIIa.
Excessive bleeding from superficial cuts
MedGen UID:
868218
Concept ID:
C4022610
Pathologic Function
An abnormally increased degree of bleeding following a superficial injury to the surface of the skin.
Impaired ristocetin-induced platelet aggregation
MedGen UID:
868749
Concept ID:
C4023154
Pathologic Function
Abnormal response to ristocetin as manifested by reduced or lacking aggregation of platelets upon addition of ristocetin.
Impaired collagen-induced platelet aggregation
MedGen UID:
870264
Concept ID:
C4024703
Finding
Abnormal response to collagen or collagen-mimetics as manifested by reduced or lacking aggregation of platelets upon addition collagen or collagen-mimetics.
Impaired epinephrine-induced platelet aggregation
MedGen UID:
870285
Concept ID:
C4024727
Finding
Abnormal response to epinephrine as manifested by reduced or lacking aggregation of platelets upon addition of epinephrine.
Impaired ADP-induced platelet aggregation
MedGen UID:
870824
Concept ID:
C4025282
Finding
Abnormal platelet response to ADP as manifested by reduced or lacking aggregation of platelets upon addition of ADP.
Impaired clot retraction
MedGen UID:
1376447
Concept ID:
C4476985
Finding
Platelets contain contractile proteins (actin and myosin) that induce clot retraction. As the platelets contract, they pull on the surrounding fibrin strands, squeezing serum form the mass, compacting the clot and drawing the ruptured edges of the blood vessel more closely together. Clot retraction is directly proportional to the platelet count and inversely proportional to the fibrinogen concentration.
Ecchymosis
MedGen UID:
8524
Concept ID:
C0013491
Finding
A purpuric lesion that is larger than 1 cm in diameter.
Purpura
MedGen UID:
19584
Concept ID:
C0034150
Disease or Syndrome
Purpura (from Latin
Bruising susceptibility
MedGen UID:
140849
Concept ID:
C0423798
Finding
An ecchymosis (bruise) refers to the skin discoloration caused by the escape of blood into the tissues from ruptured blood vessels. This term refers to an abnormally increased susceptibility to bruising. The corresponding phenotypic abnormality is generally elicited on medical history as a report of frequent ecchymoses or bruising without adequate trauma.

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVGlanzmann thrombasthenia
Follow this link to review classifications for Glanzmann thrombasthenia in Orphanet.

Professional guidelines

PubMed

Fiore M, d'Oiron R, Pillois X, Alessi MC
Br J Haematol 2018 Apr;181(2):173-182. Epub 2018 Apr 2 doi: 10.1111/bjh.15087. PMID: 29611179
Poon MC, Di Minno G, d'Oiron R, Zotz R
Transfus Med Rev 2016 Apr;30(2):92-9. Epub 2016 Jan 30 doi: 10.1016/j.tmrv.2016.01.001. PMID: 26968829
Nurden AT, Pillois X, Nurden P
Expert Rev Hematol 2012 Oct;5(5):487-503. doi: 10.1586/ehm.12.46. PMID: 23146053

Recent clinical studies

Etiology

Grainger JD, Thachil J, Will AM
Br J Haematol 2018 Sep;182(5):621-632. Epub 2018 Aug 17 doi: 10.1111/bjh.15409. PMID: 30117143
Fiore M, d'Oiron R, Pillois X, Alessi MC
Br J Haematol 2018 Apr;181(2):173-182. Epub 2018 Apr 2 doi: 10.1111/bjh.15087. PMID: 29611179
Nurden AT
Blood Rev 2017 Sep;31(5):287-299. Epub 2017 Apr 4 doi: 10.1016/j.blre.2017.03.005. PMID: 28395882
Poon MC, Di Minno G, d'Oiron R, Zotz R
Transfus Med Rev 2016 Apr;30(2):92-9. Epub 2016 Jan 30 doi: 10.1016/j.tmrv.2016.01.001. PMID: 26968829
Diz-Küçükkaya R
Hematology Am Soc Hematol Educ Program 2013;2013:268-75. doi: 10.1182/asheducation-2013.1.268. PMID: 24319190

Diagnosis

Botero JP, Lee K, Branchford BR, Bray PF, Freson K, Lambert MP, Luo M, Mohan S, Ross JE, Bergmeier W, Di Paola J; ClinGen Platelet Disorder Variant Curation Expert Panel
Haematologica 2020 Apr;105(4):888-894. Epub 2020 Mar 5 doi: 10.3324/haematol.2018.214239. PMID: 32139434Free PMC Article
Sandrock-Lang K, Wentzell R, Santoso S, Zieger B
Hamostaseologie 2016 Aug 3;36(3):178-86. Epub 2015 Feb 24 doi: 10.5482/HAMO-14-11-0067. PMID: 25707719
Nurden AT, Freson K, Seligsohn U
Haemophilia 2012 Jul;18 Suppl 4:154-60. doi: 10.1111/j.1365-2516.2012.02856.x. PMID: 22726100
Franchini M, Favaloro EJ, Lippi G
Clin Chim Acta 2010 Jan;411(1-2):1-6. Epub 2009 Oct 23 doi: 10.1016/j.cca.2009.10.016. PMID: 19854165
Nurden AT
Orphanet J Rare Dis 2006 Apr 6;1:10. doi: 10.1186/1750-1172-1-10. PMID: 16722529Free PMC Article

Therapy

Nurden AT
Blood Rev 2019 Jul;36:10-22. Epub 2019 Mar 20 doi: 10.1016/j.blre.2019.03.004. PMID: 31010659
Fiore M, d'Oiron R, Pillois X, Alessi MC
Br J Haematol 2018 Apr;181(2):173-182. Epub 2018 Apr 2 doi: 10.1111/bjh.15087. PMID: 29611179
Poon MC, Di Minno G, d'Oiron R, Zotz R
Transfus Med Rev 2016 Apr;30(2):92-9. Epub 2016 Jan 30 doi: 10.1016/j.tmrv.2016.01.001. PMID: 26968829
Simon D, Kunicki T, Nugent D
Haemophilia 2008 Nov;14(6):1240-9. doi: 10.1111/j.1365-2516.2008.01898.x. PMID: 19141164
Nurden AT
Orphanet J Rare Dis 2006 Apr 6;1:10. doi: 10.1186/1750-1172-1-10. PMID: 16722529Free PMC Article

Prognosis

Barg AA, Hauschner H, Luboshitz J, Livnat T, Straus T, Levy-Mendelovich S, Lubetsky A, Rosenberg N, Kenet G
Pediatr Blood Cancer 2018 Dec;65(12):e27376. Epub 2018 Sep 14 doi: 10.1002/pbc.27376. PMID: 30216638
Bannow BS, Konkle BA
Transfus Med Rev 2018 Oct;32(4):237-243. Epub 2018 Jul 12 doi: 10.1016/j.tmrv.2018.06.003. PMID: 30097224
Nurden AT, Nurden P
J Thromb Haemost 2015 Jun;13 Suppl 1:S2-9. doi: 10.1111/jth.12898. PMID: 26149024
Wiegering V, Sauer K, Winkler B, Eyrich M, Schlegel PG
Hamostaseologie 2013;33(4):305-12. Epub 2013 Jul 18 doi: 10.5482/HAMO-12-08-0014. PMID: 23868573
Nurden AT
Orphanet J Rare Dis 2006 Apr 6;1:10. doi: 10.1186/1750-1172-1-10. PMID: 16722529Free PMC Article

Clinical prediction guides

Li D, Peng J, Li T, Liu Y, Chen M, Shi X
Mol Med Rep 2021 Jun;23(6) Epub 2021 Apr 21 doi: 10.3892/mmr.2021.12088. PMID: 33880575Free PMC Article
Bannow BS, Konkle BA
Transfus Med Rev 2018 Oct;32(4):237-243. Epub 2018 Jul 12 doi: 10.1016/j.tmrv.2018.06.003. PMID: 30097224
Nurden AT, Nurden P
J Thromb Haemost 2015 Jun;13 Suppl 1:S2-9. doi: 10.1111/jth.12898. PMID: 26149024
Poon MC, d'Oiron R, Zotz RB, Bindslev N, Di Minno MN, Di Minno G; Glanzmann Thrombasthenia Registry Investigators
Haematologica 2015 Aug;100(8):1038-44. Epub 2015 May 22 doi: 10.3324/haematol.2014.121384. PMID: 26001792Free PMC Article
Seligsohn U, Peretz H
Haemostasis 1994 Mar-Apr;24(2):81-5. doi: 10.1159/000217088. PMID: 7959366

Recent systematic reviews

Bacci M, Ferretti A, Marchetti M, Alberelli MA, Falanga A, Lodigiani C, De Candia E
Blood Transfus 2022 Sep;20(5):420-432. Epub 2022 Jan 8 doi: 10.2450/2021.0119-21. PMID: 34369869Free PMC Article
Punt MC, Schuitema PCE, Bloemenkamp KWM, Kremer Hovinga ICL, van Galen KPM
Haemophilia 2020 Mar;26(2):216-227. Epub 2020 Jan 31 doi: 10.1111/hae.13927. PMID: 32004416Free PMC Article
Siddiq S, Clark A, Mumford A
Haemophilia 2011 Sep;17(5):e858-69. Epub 2011 Apr 4 doi: 10.1111/j.1365-2516.2011.02516.x. PMID: 21457404

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...